Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Background: The impact of chronic health conditions (CHCs) on serostatus post-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is unknown. Methods: We assessed serostatus post-SARS-CoV-2 vaccination among fully vaccinated adult residents of Jefferson County, Kentucky, USA, fr...

Full description

Bibliographic Details
Main Authors: Alok R. Amraotkar, Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, Shesh N. Rai, Aruni Bhatnagar
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Vaccines
Subjects:
SARS-CoV-2 antibody
antibody response
serology
serostatus
comorbidity
Online Access:https://www.mdpi.com/2076-393X/10/8/1363

Internet

https://www.mdpi.com/2076-393X/10/8/1363

Similar Items